What is respiratory syncytial virus (RSV)?

Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe illness in individuals with chronic obstructive pulmonary disease (COPD).

RSV primarily affects the lungs and respiratory tract, leading to symptoms such as coughing, wheezing, and shortness of breath. In individuals with COPD, RSV infection can exacerbate existing respiratory issues and potentially lead to serious complications.

Prevention and early detection are crucial in managing RSV in COPD patients. It is recommended that individuals with COPD receive the annual high-dose flu vaccine, as RSV can often be mistaken for influenza. It is also recommended that Canadian adults over 65 keep up-to-date with their COVID-19 vaccines. Practicing good hand hygiene, avoiding close contact with sick individuals, and maintaining a healthy lifestyle can help reduce the risk of viral infection. 

How prevalent is RSV and is it a seasonal virus?

Respiratory Syncytial Virus (RSV) is a common respiratory virus that affects people of all ages, including those with Chronic Obstructive Pulmonary Disease (COPD). RSV is highly prevalent, especially among infants and young children. It is estimated that almost all children will have been infected with RSV by the age of 2.

RSV is primarily a seasonal virus, with outbreaks occurring during the fall, winter, and early spring months. The virus spreads through respiratory droplets when an infected person coughs or sneezes. It can also survive on surfaces, making it easy to transmit from person to person. Individuals with COPD should take extra precautions during RSV season to reduce their risk of infection. 

In adults, RSV infections are less common than with children but can still occur, particularly in individuals with weakened immune systems or underlying respiratory conditions like COPD. RSV can cause exacerbations of COPD, leading to worsening symptoms such as increased coughing, wheezing, and shortness of breath.

If you have COPD and suspect you may have been exposed to RSV or are experiencing worsening symptoms, it is important to seek medical attention promptly. Your healthcare provider can evaluate your condition and provide appropriate treatment to manage the exacerbation and prevent further complications.

Is there a way to avoid catching the respiratory syncytial virus?

One effective way to prevent RSV infection in individuals with COPD is through vaccination. The RSV vaccine can help to reduce the risk of developing severe respiratory complications associated with the virus. 

In addition to vaccination, there are other preventive measures that can be taken. These include practicing good hand hygiene by washing hands frequently with soap and water, avoiding close contact with individuals who have respiratory infections, and maintaining a clean and hygienic environment. It is also important for individuals with COPD to follow their prescribed treatment plan, including taking medications as directed, and regularly attending medical check-ups. These measures can not only help manage COPD symptoms but can also reduce the risk of serious complications from respiratory infections like RSV.

RSV in Adults - An educational video from the American Lung Association

Respiratory Syncytial Virus (RSV) is the most common cause of lower respiratory tract infections. Most people develop only mild symptoms similar to that of a common cold, however it can be severe and even life threatening for certain adults at high risk. 

RSV and Older Adults

Being an older adult with a lung condition like COPD can put you at risk for serious complications due to respiratory syncytial virus

While you may be doing everything you can to stay healthy, the immune system (your body’s defense against infection) also ages as you age and can, therefore, have a harder time fighting off viruses such as RSV.

While RSV is typically mild, older adults are at greater risk of severe respiratory syncytial virus infection.

Respiratory Syncytial Virus (RSV) can cause serious complications such as pneumonia or exacerbation of asthma, chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) in older adults.


© Copyright COPD Canada 2023 All rights reserved.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.